[Clinical effect of a new 1-4-dihydropyridine derivative, YC-93, in patients with cerebrovascular diseases (author's transl)].
D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D006801:Humans; D009578:Nitrobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents